Invega
Brand for: Paliperidone er
My Prescription
Payment
Select pharmacy
$36.99
Print or send this coupon to your phone
CVSPowered byAbout Invega
Drug Details
Paliperidone, marketed under the brand name Invega, is an atypical antipsychotic medication designed to manage mental health conditions such as schizophrenia and schizoaffective disorder. It functions by adjusting the levels of dopamine and serotonin in the brain, which aids in stabilizing mood, thoughts, and behaviors. Paliperidone is available as an extended-release tablet, allowing for a slow release of the drug in the body, and is typically taken once daily. Some patients may experience side effects like drowsiness and involuntary muscle movements. Additionally, there are long-acting injectable forms of this medication, which must be administered by a healthcare provider. Always consult your healthcare provider to ensure this medication is appropriate for your condition.
Price history for Invega (brand) & Paliperidone ER (generic)
30 Tablet Extended Release 24 Hours, 1.5MG
Average retail price for Invega
Average retail price for Paliperidone ER
Average SaveHealth price for Paliperidone ER
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
Over the last 12 months, the average discount price of Invega is $41.34 using the SaveHealth savings card. That's an average savings of 96.85% on Invega with our discount card.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Invega (Paliperidone ER) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 1.5MG | 30 Tablet Extended Release 24 Hours | $36.99 | $1.23 |
| 3MG | 1 Tablet Extended Release 24 Hour | $15.53 | $15.53 |
| 3MG | 30 Tablet Extended Release 24 Hours | $36.99 | $1.23 |
| 3MG | 100 Tablet Extended Release 24 Hours | $76.93 | $0.77 |
| 6MG | 1 Tablet Extended Release 24 Hour | $15.85 | $15.85 |
| 6MG | 30 Tablet Extended Release 24 Hours | $36.99 | $1.23 |
| 6MG | 100 Tablet Extended Release 24 Hours | $76.93 | $0.77 |
Invega FAQs
Invega is an antipsychotic medication used to treat certain mental/mood disorders such as schizophrenia and schizoaffective disorder. It works by helping to restore the balance of certain natural substances in the brain, which can help reduce symptoms like hallucinations, delusions, and improve concentration.
Invega and Abilify are not the same. They are both antipsychotic medications but have different active ingredients and may be used to treat different conditions. Invega contains paliperidone, while Abilify contains aripiprazole. Their mechanisms of action and side effect profiles also differ. It is important for patients to follow their healthcare provider's guidance when using these medications.
Invega (paliperidone) and Risperdal (risperidone) are not the same, but they are related. Invega is the active metabolite of Risperdal, meaning it is a product formed when Risperdal is metabolized in the body. Both medications are antipsychotics used to treat similar conditions, such as schizophrenia, but they have different formulations and dosing.
Invega (paliperidone) is primarily used to treat schizophrenia and schizoaffective disorder. It is not typically prescribed for anxiety disorders. While some patients may experience a reduction in anxiety symptoms as a secondary effect, it is not considered a first-line treatment for anxiety. It is important for individuals to consult with their healthcare provider to determine the most appropriate medication for their specific condition.
Invega (paliperidone) is generally associated with a higher risk of weight gain compared to Abilify (aripiprazole). While both medications can lead to weight gain, Invega tends to have a more pronounced effect in this regard. However, individual responses can vary, and it is important for patients to discuss any concerns about weight gain with their healthcare provider.